VYNT
Price:
$0.194
Market Cap:
$0
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.
Industry
Biotechnology
IPO Date
2021-04-01
Stock Exchange
NASDAQ
Ticker
VYNT
According to Vyant Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.14. This represents a change of 27.46% compared to the average of 2.46 of the last 4 quarters.
The mean historical Current Ratio of Vyant Bio, Inc. over the last ten years is 2.91. The current 3.14 Current Ratio has changed 10.68% with respect to the historical average. Over the past ten years (40 quarters), VYNT's Current Ratio was at its highest in in the March 2014 quarter at 17.93. The Current Ratio was at its lowest in in the March 2013 quarter at 0.15.
Average
2.91
Median
2.49
Minimum
0.34
Maximum
7.28
Discovering the peaks and valleys of Vyant Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.18%
Maximum Annual Current Ratio = 7.28
Minimum Annual Increase = -71.02%
Minimum Annual Current Ratio = 0.34
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 3.14 | -26.53% |
| 2021 | 4.27 | 390.10% |
| 2020 | 0.87 | -15.29% |
| 2019 | 1.03 | 200.63% |
| 2018 | 0.34 | -71.02% |
| 2017 | 1.18 | -44.28% |
| 2016 | 2.12 | -25.81% |
| 2015 | 2.86 | -60.72% |
| 2014 | 7.28 | 20.89% |
| 2013 | 6.02 | 3.18% |
The current Current Ratio of Vyant Bio, Inc. (VYNT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.76
5-year avg
1.93
10-year avg
2.91
Vyant Bio, Inc.’s Current Ratio is less than CohBar, Inc. (15.69), greater than Timber Pharmaceuticals, Inc. (1.95), less than 9 Meters Biopharma, Inc. (0), less than NeuBase Therapeutics, Inc. (5.92), greater than Altamira Therapeutics Ltd. (1.38), less than InVivo Therapeutics Holdings Corporation (7.13), less than Impel Pharmaceuticals Inc. (3.60), greater than Oncternal Therapeutics, Inc. (2.39), less than Cassava Sciences, Inc. Warrant (0), less than Bellicum Pharmaceuticals, Inc. (6.31),
| Company | Current Ratio | Market cap |
|---|---|---|
| 15.69 | $1.19M | |
| 1.95 | $1.18M | |
| 0 | $1.45K | |
| 5.92 | $1.42M | |
| 1.38 | $1.13M | |
| 7.13 | $995.92K | |
| 3.60 | $956.00K | |
| 2.39 | $1.56M | |
| 0 | $1.45M | |
| 6.31 | $778.33K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vyant Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vyant Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Vyant Bio, Inc.'s Current Ratio?
How is the Current Ratio calculated for Vyant Bio, Inc. (VYNT)?
What is the highest Current Ratio for Vyant Bio, Inc. (VYNT)?
What is the 3-year average Current Ratio for Vyant Bio, Inc. (VYNT)?
What is the 5-year average Current Ratio for Vyant Bio, Inc. (VYNT)?
How does the current Current Ratio for Vyant Bio, Inc. (VYNT) compare to its historical average?